doxercalciferol
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
12 FDA-registered drug labelers
Alembic Pharmaceuticals Inc.
Assia Chemical Industries Ltd - Teva Tech Site
Catalent Pharma Solutions LLC
Cerbios-Pharma SA
Chartwell RX, LLC
Dr.Reddy's Laboratories Inc
Eugia US LLC
Formosa Laboratories, Inc.
Gland Pharma Limited
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Meitheal Pharmaceuticals Inc.
Sai Life Sciences Limited
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Doxercalciferol
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Doxercalciferol Injection
12/10/2025Chemical Identity
CAS54573-75-0
PubChem CID5281107
DTXSIDDTXSID1034214
FormulaC28H44O2
Mol. Weight412.6 g/mol
SMILESCC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C
Data Sources
52811072026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/doxercalciferol/cids/JSON
Archive: data/sources/pubchem_name/doxercalciferol.json
CAS 54573-75-02026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 54573-75-02026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json